NewsOur news BioVersys in the NewsFresh funds to fuel the fight against drug-resistant bacteriaNewsBiosystems Technology, BioVersys and Voxcan announce funding by EurostrasNewsEurostars Funds IMPACT2 To Establish A Break-Through Translational AMR PlatformBioVersys in the NewsAn interesting and informative report on bacteria and antibiotic resistanceNewsBioVersys and Institut Pasteur de Lille Working TogetherBioVersys in the NewsIncrease In Antibacterial R&D Prompts EMA Proposal For Improved GuidanceNewsBioVersys AG successfully closes Series A2 financing roundBioVersys in the NewsBeobachter 10/2017: Die Tuberkulose überlistet. Ein Interview mit Marc GitzingerBioVersys in the NewsAMR Industry report and case study BioVersys 123…56Next »
BioVersys in the NewsBeobachter 10/2017: Die Tuberkulose überlistet. Ein Interview mit Marc Gitzinger